Novo Nordisk A/S
$39.74
-8.09%(-3.50)
▼Why is $NVO Down Today?
$NVO is down 8.09% today. Check the latest news below for potential catalysts.
For educational purposes only
30-Day Price History
AlphaFeed Signal History
Full tracker →US-listed shares of Novo Nordisk jumped 3% after the Danish drugmaker announced a partnership with OpenAI to accelerate AI-driven drug discovery. The deal expands pharma's AI buildout and pairs a GLP-1 giant with the leading AI lab.
Risk: Partnership may lack near-term revenue impact; market could fade hype quickly.
Latest News
Novo Nordisk Targets Over Five New Blockbusters By 2030, But NVO Stock Slides On Growth Concerns
Yahoo
Novo Nordisk stock falls after 2030 strategy disappoints investors
Yahoo
At Novo Nordisk Capital Markets Day, Co. CEO Says I Would Not Rule Out Acquiring Products Or Assets Which Are Already On The Market; Financial Impact From Compounders Has Gotten Less And Less
Benzinga
Novo Nordisk Shares Fall 6% as Drugmaker Outlines Growth Targets Through 2030
Yahoo
Novo's CagriSema delivers superior weight loss versus tirzepatide in REIMAGINE 5 trial
Yahoo
Key Stats
Track this ticker
AlphaFeed HQ content is for educational purposes only. This is not financial advice. Do not buy, sell, or hold any security based on this content. Always conduct your own research and consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. AlphaFeed HQ is not a registered investment advisor. For educational purposes only.